This new Evidence-Based Practices Resource Center aims to provide communities, clinicians, policy-makers and others in the field with the information and tools they need to incorporate evidence-based practices into their communities or clinical settings. The Resource Center contains a collection of scientifically-based resources for a broad range of audiences, including Treatment Improvement Protocols, toolkits, resource guides, clinical practice guidelines, and other science-based resources.
Evidence-Based Practices Resource Center
This guide provides information and practices that behavioral health providers can implement in their daily practice with patients or clients who are involved in the criminal justice system.
This document provides guidance to assist state policymakers and practitioners in reforming, implementing, and appropriately targeting commitment law and practice.
This manual offers best practices to states, tribes, and local communities on collaborative treatment approaches for pregnant women living with opioid use disorders, and the risks and benefits associated with medication-assisted treatment (MAT).
This report provides background and practical information promoting the use of psychiatric advance directives as a tool for self-directed care in psychiatric treatment, progress toward parity in mental health, and supporting crisis planning and the rights of persons who live with mental illness.
The purpose of this training is to provide educators, friends, and family members with basic knowledge about violence in youth; understand protective and risk factors associated with violent behaviors in youth; provide basic knowledge about the connection of mental illnesses and violence; provide information about mental illness in youth; and provide opportunities and strategies that teachers, family members, and friends can use to manage situations of concern.
This abstract lists the standards that NADCP has developed for adult Drug Courts. Vol 1 represents the first of two parts covering best practice standards for a variety of topics.
This abstract lists the standards that NADCP has developed for adult Drug Courts. Vol 2 represents the second of two parts covering best practice standards for a variety of topics.
This guide highlights the use of medication-assisted treatment (MAT) for opioid use disorder in drug courts.
This advisory summarizes data on the use of sublingual and transmucosal buprenorphine as part of medication-assisted treatment (MAT) for opioid use disorder.
This toolkit for schools assists schools in implementing a coordinated response to the suicide death of a student.
This is a summary of a systematic review evaluating the evidence regarding the efficacy, comparative effectiveness, and adverse effects of medications in adults with Alcohol Use Disorder.
This report provides current, comprehensive data on the use of restricted housing, and also documents efforts across the country to reduce the number of people in restricted housing and to reform the conditions in which isolated prisoners are held in order to improve safety for prisoners, staff, and communities at large.
With this Guide, the National Institute on Alcohol Abuse and Alcoholism introduces a simple, quick, empirically derived tool for identifying youth at risk for alcohol-related problems.
Systematic evidence review examining comparative effectiveness and harms of psychotherapy and medications for childhood anxiety disorders panic disorder, social anxiety disorder, specific phobias, generalized anxiety disorder, and separation anxiety.
The ASAM criteria is the most widely used and comprehensive set of guidelines for placement, continued stay and transfer/discharge of patients with addiction and co-occurring conditions.
ASAM developed the Appropriate Use of Drug Testing in Clinical Addiction Medicine document to provide guidance about the effective use of drug testing in the identification, diagnosis, treatment and promotion of recovery for patients with, or at risk for, addiction.
The American Society of Addiction Medicine (ASAM) developed this National Practice Guideline for the Use of Medications in the Treatment of Addiction Involving Opioid Use to provide information on evidence-based treatment of opioid use disorder.